Lund, Sweden

Jan P Sternby

This inventor holds 69 USPTO granted patents and 7 published patent applications, plus 6 CIPO patents and 41 EPO patents, primarily in Extracorporeal Blood Treatment (CPC class A61M). Top assignees: Gambro Lundia Ab, Gambro Ab, Hospal Industrie. Active years: 1988-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan P Sternby. Retrieved from https://idiyas.com/inventor/jan-p-sternby

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 69 

% Patents Active = 87.0


 

Average Co-Inventor Count = 2.1

ph-index = 20

Forward Citations = 1,408(Granted Patents)

Forward Citations (Not Self Cited) = 1,286(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 1988-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Extracorporeal Blood Treatment
Dialysis Machines
Anticoagulation Systems
Fluid Monitoring
Pressure Pulses
Fluid Transfer
Citrate Anticoagulation
Medical Solutions
Ultrafiltration Device
Fluid Connection Integrity
Blood Processing Apparatus
Heat Exchanger
69 patents (USPTO):Explore Patents

Title: The Innovative Mind of Jan P Sternby: Revolutionizing Blood Treatment Machines

Introduction: Jan P Sternby, a highly skilled inventor based in Lund, SE, has gained a reputation for his remarkable contributions to the field of extracorporeal blood treatment. With an impressive portfolio of 62 patents, Sternby's groundbreaking inventions have significantly impacted the healthcare industry.

Latest Patents: One of Jan P Sternby's latest patents includes a "Connection test for blood treatment machines," which involves a control device that detects connection errors in blood treatment machines. By computing efficiency change parameters based on sensor signals, this invention ensures the smooth operation of dialyzers and access devices during blood treatment procedures.

Another notable patent by Sternby is an "Apparatus for extracorporeal blood treatment," which features a filtration unit, a preparation device for dialysis fluid, and a sensor for measuring conductivity. This invention allows for precise regulation of dialysis fluid composition, enhancing the overall quality of extracorporeal blood treatment.

Career Highlights: Sternby has made significant contributions to companies such as Gambro Lundia AB and Gambro AB, where his innovative spirit and expertise have been instrumental in advancing blood treatment technologies. His inventive solutions have set new standards in the industry and have improved the efficiency and effectiveness of blood treatment processes.

Collaborations: Throughout his career, Jan P Sternby has collaborated with talented individuals such as Kristian Solem and Bo Olde. These partnerships have led to the development of cutting-edge technologies and have paved the way for advancements in the field of extracorporeal blood treatment.

Conclusion: Jan P Sternby's relentless pursuit of innovation and his passion for improving healthcare technologies have solidified his position as a pioneering inventor in the realm of blood treatment machines. With a remarkable track record of patents and collaborations, Sternby continues to drive progress and excellence in the field, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…